Login / Signup

The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.

David T RubinJenny GriffithQisu ZhangZsolt HeppAllison Keshishian
Published in: Inflammatory bowel diseases (2022)
These results suggest that anti-TNF treatment after, rather than before, a patient develops complications leads to a higher economic burden. However, these findings could also result from patients with more severe disease having early complications that are more difficult to treat.
Keyphrases
  • patients with inflammatory bowel disease
  • healthcare
  • risk factors
  • rheumatoid arthritis
  • early onset
  • case report
  • newly diagnosed
  • drug induced
  • health information